Patents by Inventor Van T. HOANG

Van T. HOANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230100458
    Abstract: Disclosed are anthranilic amide derivatives having the formula: Compositions are disclosed that include the anthranilic amide derivatives and the use of the anthranilic amide derivatives for the manufacture of a medicament. Further disclosed are methods of inhibiting or treating cancer, inhibiting or reversing an epithelial to mesenchymal cellular transition, and/or inhibiting MEK1/2 and/or MEK 5 enzymatic activity in a subject by administering to the subject an effective amount of a disclosed anthranilic amide derivative.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 30, 2023
    Inventors: Suravi CHAKRABARTY, Patrick T. FLAHERTY, Darlene MONLISH, Jane E. CAVANAUGH, Matthew E. BUROW, Steven ELLIOTT, Van T. HOANG
  • Patent number: 11465978
    Abstract: Disclosed are anthranilic amide derivatives having the formula. Compositions are disclosed that include the anthranilic amide derivatives and the use of the anthranilic amide derivatives for the manufacture of a medicament. Further disclosed are methods of inhibiting or treating cancer, inhibiting or reversing an epithelial to mesenchymal cellular transition, and/or inhibiting MEK1/2 and/or MEK 5 enzymatic activity in a subject by administering to the subject an effective amount of a disclosed anthranilic amide derivative.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: October 11, 2022
    Assignees: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, DUQUESNE UNIVERSITY OF THE HOLY GHOST
    Inventors: Suravi Chakrabarty, Patrick T. Flaherty, Darlene Monlish, Jane E. Cavanaugh, Matthew E. Burow, Steven Elliott, Van T. Hoang
  • Publication number: 20160221975
    Abstract: Disclosed are anthranilic amide derivatives having the formula. Compositions are disclosed that include the anthranilic amide derivatives and the use of the anthranilic amide derivatives for the manufacture of a medicament. Further disclosed are methods of inhibiting or treating cancer, inhibiting or reversing an epithelial to mesenchymal cellular transition, and/or inhibiting MEK1/2 and/or MEK 5 enzymatic activity in a subject by administering to the subject an effective amount of a disclosed anthranilic amide derivative.
    Type: Application
    Filed: September 11, 2014
    Publication date: August 4, 2016
    Inventors: Suravi CHAKRABARTY, Patrick T. FLAHERTY, Darlene MONLISH, Jane E. CAVANAUGH, Mattthew E. BUROW, Steven ELLIOTT, Van T. HOANG